-
INNOVATIVE GRAPH BASED CLUSTERING TO IDENTIFY SJÖGREN’S DISEASE SUBTYPES FROM REAL-WORLD DIAGNOSTIC JOURNEYS
Feb 25, 2026, 14:41 PM -
REAL-WORLD DISEASE ACTIVITY AND TREATMENT RESPONSIVENESS AMONG ADULTS WITH RHEUMATOID ARTHRITIS
Feb 25, 2026, 14:41 PM -
THE UNINTENDED CONSEQUENCES OF THE INFLATION REDUCTION ACT ON BIOSIMILAR MARKET INCENTIVES AND MEDICARE SAVINGS
Feb 25, 2026, 14:41 PM -
EVALUATING AI MODELS FOR DRUG PRICING ANALYTICS: A COMPARATIVE STUDY FOR MOST-FAVORED-NATION POLICY MODELING
Feb 25, 2026, 14:41 PM -
HOSPITALIZED PATIENT WITH ASTHMA IN JORDAN: A CLINICAL AND ECONOMIC INVESTIGATION
Feb 25, 2026, 14:41 PM -
THE ILLUSION OF COMPLIANCE: WHY ECOA-ONLY MONITORING FALLS SHORT IN DETECTING AND ADDRESSING DATA GAPS
Feb 25, 2026, 14:41 PM -
ENSURING ESTIMAND AND POPULATION CONSISTENCY ACROSS HEALTH TECHNOLOGY ASSESSMENT DOSSIER COMPONENTS
Feb 25, 2026, 14:41 PM -
WHEN NOT TO USE ARTIFICIAL INTELLIGENCE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH
Feb 25, 2026, 14:41 PM -
PHYSICALLY IMPOSSIBLE EFFECTS? PRIOR-PREDICTIVE TESTS SUGGEST MANY BAYESIAN ITCS LACK CREDIBILITY
Feb 25, 2026, 14:41 PM -
EXPLANATION AND ELABORATION OF THE DEEM-Q CHECKLIST: GUIDANCE FOR ASSESSING THE METHODOLOGICAL QUALITY OF ECONOMIC EVALUATIONS OF MEDICAL DEVICES
Feb 25, 2026, 14:41 PM -
ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICIAN DENSITY AND HEALTHCARE EXPENDITURE IN JAPAN:USING LARGE-SCALE REAL-WORLD DATA OF EMPLOYMENT-BASED HEALTH INSURANCE CLAIMS (WELLNESS STAR DATABASE)
Feb 25, 2026, 14:41 PM -
GENERATIVE AI POWERED EXTRACTION AND RECALIBRATION OF NON STANDARDIZED SPREADSHEET TEMPLATES, ENABLING TOUCHLESS AUTOMATION OF DOWNSTREAM PROCESSES
Feb 25, 2026, 14:41 PM -
MEASURING MEANINGFUL ENGAGEMENT: A PATIENT ENGAGEMENT METRICS FRAMEWORK FOR PATIENT-GENERATED PRIMARY DATA QUALITY
Feb 25, 2026, 14:41 PM -
SYNTHETIC PROGRESSION-FREE SURVIVAL DATA GENERATION FROM PUBLISHED AGGREGATE TRIAL DATA
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF LEBRIKIZUMAB VERSUS NEMOLIZUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE US: A 10-YEAR ECONOMIC EVALUATION
Feb 25, 2026, 14:41 PM -
IDENTIFYING MIGRAINE IN PRIMARY CARE WORKFLOWS: PREVALENCE, RISK SIGNALS, AND PREDICTIVE TOOLS
Feb 25, 2026, 14:41 PM -
DEVELOPING THE FIRST PRAGMATIC DOSE CONVERSION BETWEEN LONG-ACTING AND DAILY GROWTH HORMONE IN PREPUBERTAL CHILDREN WITH IDIOPATHIC SHORT STATURE: A JOINT MODELING METHOD USING REAL-WORLD DATA IN CHINA
Feb 25, 2026, 14:41 PM -
GLOBAL LANDSCAPE OF ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT: TRENDS, GOVERNANCE, AND EMERGING PRACTICES
Feb 25, 2026, 14:41 PM -
GLP-1RA AND RISK OF INCIDENT OPIOID USE DISORDER IN T2D: IMPLICATIONS FOR DRUG REPURPOSING
Feb 25, 2026, 14:41 PM -
SHIFTING THE LENS FROM EVENT RATES TO DAYS ALIVE AND OUT OF HOSPITAL (DAOH) AS A PATIENT-CENTERED PERFORMANCE METRIC: 30-DAY AND 1-YEAR TRENDS AND EQUITY AFTER HEART FAILURE HOSPITALIZATION IN SINGAPORE
Feb 25, 2026, 14:41 PM
